114 related articles for article (PubMed ID: 10445674)
1. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
Straznicka M; Gong G; Yan L; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 1999 Aug; 34(2):229-36. PubMed ID: 10445674
[TBL] [Abstract][Full Text] [Related]
2. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
3. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy.
Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR
Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR
Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530
[TBL] [Abstract][Full Text] [Related]
5. Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes.
Engel S; Yan L; Weiss H; Scholz P
Eur J Pharmacol; 2001 Jun; 421(1):23-30. PubMed ID: 11408045
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction of a beta-adrenergic agonist and cyclic GMP phosphodiesterase inhibitor in control and hypertrophic cardiomyocytes.
Zhang S; Rodriguez R; Scholz PM; Weiss HR
Pharmacology; 2006; 76(2):53-60. PubMed ID: 16276122
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
[TBL] [Abstract][Full Text] [Related]
8. Decreasing cyclic GMP exerts similar positive functional effects on cardiac myocytes regardless of initial level.
Yan L; Huang MW; Scholz PM; Weiss HR
Pharmacology; 2000 Jul; 61(1):51-6. PubMed ID: 10895081
[TBL] [Abstract][Full Text] [Related]
9. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR
Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647
[TBL] [Abstract][Full Text] [Related]
10. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
Gandhi A; Yan L; Scholz PM; Huang MW; Weiss HR
Nitric Oxide; 1999 Dec; 3(6):473-80. PubMed ID: 10637126
[TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes.
Yan L; Zhang Q; Scholz PM; Weiss HR
Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):943-50. PubMed ID: 14678234
[TBL] [Abstract][Full Text] [Related]
13. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts.
Weiss HR; Rodriguez E; Tse J; Scholz PM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120
[TBL] [Abstract][Full Text] [Related]
14. Interaction between cyclic GMP protein kinase and cyclic AMP may be diminished in stunned cardiac myocytes.
Yan L; Patel KN; Zhang Q; Scholz PM; Weiss HR
Eur J Pharmacol; 2001 Aug; 426(1-2):11-9. PubMed ID: 11525765
[TBL] [Abstract][Full Text] [Related]
15. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
Katz E; Zhang Q; Weiss HR; Scholz PM
Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
[TBL] [Abstract][Full Text] [Related]
16. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms.
Zhang Q; Lazar M; Yan L; He Y; Tse J; Weiss HR; Scholz PM
J Cardiovasc Pharmacol; 2004 Aug; 44(2):235-43. PubMed ID: 15243306
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
Tan T; Scholz PM; Weiss HR
Life Sci; 2010 Jul; 87(1-2):9-16. PubMed ID: 20470788
[TBL] [Abstract][Full Text] [Related]
18. cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension.
Straznicka M; Gong G; Tse J; Scholz PM; Weiss HR
Am J Physiol; 1997 Oct; 273(4):H1949-55. PubMed ID: 9362265
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible factor-1 protects against nitrate tolerance and stunning in rabbit cardiac myocytes.
Tan T; Weiss HR
Cardiovasc Drugs Ther; 2010 Apr; 24(2):95-106. PubMed ID: 20405315
[TBL] [Abstract][Full Text] [Related]
20. Relationship between decreased function and O2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels.
Yan L; Gong GX; Tse J; Scholz PM; Weiss HR
Res Exp Med (Berl); 1998 Oct; 198(3):109-21. PubMed ID: 9820898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
